← Back to Browse
ProductIT Systems and IT Solutions

AITRICS SEPS (Sepsis Prediction System)

South Korea

A deep learning-based predictive analytics platform specifically designed for early detection of pneumonia-associated sepsis and patient deterioration. The system processes irregular clinical time series data to provide clinicians with actionable alerts for timely intervention.

Manufactured by

AITRICS

South Korea

AITRICS is a medical AI company co-founded by professors from Severance Hospital and KAIST in November 2016. We provide AI-based medical services equipped with world-class AI technology and clinical problem-solving capabilities. Based on these technological capabilities and potential, AITRICS has attracted a total investment of USD 2,410 million through Series A in 2019 worth USD 5.5 million and Series B in 2024 worth USD 18.6 million. And we continue to actively collaborate with large domestic hospitals, top-tier hospitals overseas, and leading companies. In the future, AITRICS will apply its outstanding technology to expand its business into various fields such as finance, insurance, and entertainment, and will do its best to ensure that the public can enjoy high-quality medical services.

View profile & products →

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

0
Relevant manufacturers
matched to this product
0
Relevant products analyzed
for supplier coverage
0
Sourcing countries
identified

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

3 of 92 closest product alternatives

92 products

89 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products